FierceBiotechFierceBioResearcherFierceVaccinesFiercePharma   FierceHealthcare
About | Sample | Privacy
Related Topics >> vaccines | bird flu | H5N | China

SPOTLIGHT: Vaccine a success for human-to-human H5N1 case

Tools


A confirmed case of bird flu in China has confirmed that the threat of human-to-human contagion is still largely limited to the blood relatives of those infected. In an important case for vaccine developers, the man recovered after he was given plasma drawn from a woman who had received an experimental bird flu vaccine that had been made from whole, killed H5N1. The vaccine was made by Sinovac from a 2004 Vietnamese strain of the disease. If researchers can show that the recovery was linked to the vaccine, the whole virus vaccine could prove a key to spurring immunity to a range of possible mutations of H5N1. Report

More stories about vaccines   bird flu   H5N   China  

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

What is 47 + 20?
To combat spam, please solve the math question above.